EZH2 and myeloid neoplasm: In contrast to B-cell lymphomas, which are characterized by localized gain-of-function EZH2 mutations, mutations in myeloid malignancies were found to be spread throughout the gene, comprising largely missense, frameshift and nonsense mutations, with missense mutations often located in the CXC/SET or D2 domains.